The helix-loop-helix Id-1 inhibits PSA expression in prostate cancer cells

International Journal of Cancer

Volumn 126, Issue 10, 2010, Pages 2490-2496

  Zielinski, Anne J ^a   Fong, Sylvia ^a   Allison, Juanita ^a   Kawahara, Misako ^a   Coppe, Jean Philippe ^a   Feiler, Heidi ^b   Lee, Nancy M ^a   Desprez, Pierre Yves ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Androgen receptor; Prostate acid phosphatase; Prostate specific antigen; Transcriptional regulator

Indexed keywords

INHIBITOR OF DIFFERENTIATION 1; KALLIKREIN; KALLIKREIN 3; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; HELIX LOOP HELIX PROTEIN; ID1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; CARCINOMA; COMPARATIVE STUDY; DISEASE COURSE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELIX-LOOP-HELIX MOTIFS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77951214454     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24811     Document Type: Article

References (32)

1. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93: 824-842
2. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59. (Pubitemid 20134378)
3. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000; 20:429-440. (Pubitemid 30023084)
4. Chetcuti A, Margan S, Mann S, Russell P, Handelsman D, Rogers J, Dong Q. Identification of differentially expressed genes in organ- confined prostate cancer by gene expression array. Prostate 2001;47: 132-140 (Pubitemid 32336583)
5. Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002;160:2169-2180
6. Perk J, Gil-Bazo I, Chin Y, de Candia P, Chen JJ, Zhao Y, Chao S, Cheong W, Ke Y, Al-Ahmadie H, Gerald WL, Brogi E, et al. Reassessment of Id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res 2006;66:10870-10877
7. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC. Up-regulation of TRPM- 2,TRPM-2. MMP-7 and. ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat. Carcinogenesis 2001;22: 965-973
8. Ling MT, Wang X, Tsao SW, Wong YC. Down-regulation of Id-1 expression is associated with TGF beta 1-induced growth arrest in prostate epithelial cells. Biochim Biophys Acta 2002;1570:145-152 (Pubitemid 34518594)
9. Ouyang XS, Wang X, Lee DT, Tsao SW, Wong YC. Over expression of ID-1 in prostate cancer. J Urol 2002;167:2598-2602
10. Lin JC, Chang SY, Hsieh DS, Lee CF, Yu DS. The association of Id-1, MIF Id-1 MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells. Oncol Rep 2005;13:983-988
11. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang Q, Wang X, Wong YC. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 2005;26: 1668-1676 (Pubitemid 41487982)
12. Yu DS, Hsieh DS, Chang SY. Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells. Arch Androl 2006;52:275-281
13. Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, Foster CS, Ke Y. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol 2007;38: 1321-1329 (Pubitemid 47247487)
14. Asirvatham AJ, Carey JP, Chaudhary J. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate 2007;67: 1411-1420 (Pubitemid 47435787)
15. Zhang X, Ling MT, Wang Q, Lau CK, Leung SC, Lee TK, Cheung AL, Wong YC, Wang X. Identification of a novel inhibitor of differentiation-1 (ID-1. binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem 2007;282:33284-94.
16. Darby S, Cross SS, Brown NJ, Hamdy FC, Robson CN. BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J Pathol 2008;214:394-404. (Pubitemid 351212395)
17. Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, Green TP, Desprez PY, Lara PN, Gandara DR, Mack PC, Kung HJ. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res 2008;68:2250-2258 (Pubitemid 351521798)
18. Wong YC, Zhang XM, Ling MT, Wang XH. Inactivation of ID-1 gene induces sensitivity of prostate cancer cells to chemotherapeutic drugs. Adv Exp Med Biol 2008;617:565-572
19. Yu X, Xu X, Han B, Zhou R. Inhibitor of DNA binding-1 overexpression in prostate cancer: relevance to tumor differentiation. Pathol Oncol Res 2009;15:91-96
20. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 2004;10:2044-2051 (Pubitemid 38375565)
21. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines. Prostate 1997;30:58-64. (Pubitemid 27053542)
22. Varma M, Berney DM, Jasani B, Rhodes A. Technical variations in prostatic immunohistochemistry: need for standardization and stringent quality assurance in PSA and PSAP immunostaining. J Clin Pathol 2004;57: 687-690 (Pubitemid 38901480)
23. Ling MT, Wang X, Lee DT, Tam PC, Tsao SW, Wong YC. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis 2004;25:517-525 (Pubitemid 38499942)
24. Watt KW, Lee PJ, M'Timkulu T, Chan WP, Loor R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986;83:3166-3170 (Pubitemid 16042997)
25. Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev 2000;14:2410-2434
26. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004;10:387-392 (Pubitemid 39061140)
27. Ling MT, Wang X, Zhang X, Wong YC. The multiple roles of Id-1 in cancer progression. Differentiation 2006;74:481-487 (Pubitemid 44922493)
28. Mitchell S, Abel P, Ware M, Stamp G, Lalani E. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU Int 2000;85:932-944 (Pubitemid 30242804)
29. Yin H, Radomska HS, Tenen DG, Glass J. Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line. BMC Cancer 2006;6:158. (Pubitemid 44240723)
30. Kim J, Coetzee GA. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem 2004;93:233-241 (Pubitemid 44264201)
31. Hakariya T, Shida Y, Sakai H, Kanetake H, Igawa T. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells. Biochem Biophys Res Commun 2006;342:92-100. (Pubitemid 43247364)
32. Xu B, Sun Y, Tang G, Xu C, Wang L, Zhang Y, Ji J. Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor. Cancer Lett 2009;278:220-229